HomeREGULATORY
REGULATORY

Huge Seller Price Slash to Hit Nexium/Takecab; Rituxan, 8 Other Brands to Face Market Expansion Re-Pricing
(Jan.18.2018)

Chuikyo General Assembly Meeting on Jan. 17
AstraZeneca’s acid reflux drug Nexium (esomeprazole) and its rival Takecab (vonoprazan) by Takeda Pharmaceutical will be slapped with a price slash of up to 25% in Japan in April 2018 as a key reimbursement policy panel has approved the application of the “special expansion” re-pricing rule for these drugs ...
(LOG IN FOR FULL STORY)